Centralisation of services for the management of ovarian cancer: arguments for
Article first published online: 12 SEP 2007
DOI: 10.1111/j.1471-0528.2007.01460.x
RCOG 2007 BJOG An International Journal of Obstetrics and Gynaecology
Issue

BJOG: An International Journal of Obstetrics & Gynaecology
Volume 114, Issue 10, pages 1188–1190, October 2007
Additional Information
How to Cite
Olaitan, A. and McCormack, M. (2007), Centralisation of services for the management of ovarian cancer: arguments for. BJOG: An International Journal of Obstetrics & Gynaecology, 114: 1188–1190. doi: 10.1111/j.1471-0528.2007.01460.x
Publication History
- Issue published online: 12 SEP 2007
- Article first published online: 12 SEP 2007
- Accepted 11 June 2007.
- Abstract
- Article
- References
- Cited By
Keywords:
- Adjuvant therapy;
- gynaecological cancer;
- ovarian cancer;
- surgery
The recommendation in 1999, by the National Health Service Executive (NHSE) that the management of gynaecological cancer be centralised, led to a reorganisation of services for women with gynaecological malignancies. Debate has continued about the feasibility and benefits of ovarian cancer centralisation particularly because its insidious presentation can make it difficult to identify women with ovarian cancer before surgery. Despite this, there is clear evidence that centralisation is advantageous to women in terms of quality of life, morbidity and survival.

1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)